Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03945331 · ClinicalTrials.gov registry record · NA
Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03945331: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03945331 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03945331, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to compare transcutaneous electrical spinal stimulation (TESS) and epidural electrical stimulation (EES); in particular, the motor activity enabled by each method and the potential health benefits of each method.
Primary Outcome
Change in measurements of joint angles using video-based, inertial measurement, and/or electromagnetic markers.
Interventions
- DEVICE Transcutaneous spinal cord stimulator
- DEVICE Epidural spinal cord stimulation system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2020-06-17 |
| Phase | NA |
Why NCT03945331 stopped before completion
NCT03945331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Transcutaneous spinal cord stimulator is the first listed.
NCT03945331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03945331 about?
NCT03945331 is a clinical study titled "Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia". The purpose of this study is to compare transcutaneous electrical spinal stimulation (TESS) and epidural electrical stimulation (EES); in particular, the motor activity enabled by each method and the potential health benefits of each method.
What is the current status of trial NCT03945331?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-01-22. Estimated completion is 2020-06-17.
What interventions are being tested in trial NCT03945331?
The interventions under investigation include: Transcutaneous spinal cord stimulator (DEVICE), Epidural spinal cord stimulation system (DEVICE).
Who is sponsoring clinical trial NCT03945331?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03945331's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI